Skip to content

Thursday, April 3, 2025

VRT Pharma

Regulatory and Clinical Strategy Consulting

Search

Home
About Us
Fields and Areas of Specialization
Media
- Press Releases
Career
Contact Us

Home
Media

Media

Search

Recent Posts

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
US FDA approves Dupixent to treat younger kids with esophageal condition

Categories

Press Release

You may Missed

Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25

January 26, 2024

Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg

January 26, 2024

US FDA approves Dupixent to treat younger kids with esophageal condition

January 26, 2024

Copyright © 2025 VRT Pharma

Theme by: Theme Horse

Proudly Powered by: WordPress